An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers
Part of paid clinical trials in Buffalo, New York.
- Sponsor
- Roswell Park Cancer Institute
- Study ID
- NCT06414317
- Status
- Recruiting
Conditions
- Locally Advanced Bladder Carcinoma
- Metastatic Bladder Carcinoma
- Stage III Bladder Cancer AJCC v8
- Stage IV Bladder Cancer AJCC v8
- Unresectable Bladder Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Assessment of Distress — PROCEDUREUndergo psychological distress screening
- Consultation Visit — OTHERAttend consultations
- Nutritional Assessment — OTHERUndergo malnutrition screening
- Questionnaire Administration — OTHERAncillary studies
- Supportive Care — OTHERReceive access to bladder cancer ENST
- Supportive Care — OTHERAttend virtual support group meetings
Study Details
This clinical trial evaluates the impact of an education and navigation support tool (ENST) on patient and caregiver participation in care coordination for bladder cancer that has spread to nearby tissue or lymph nodes (locally advanced), to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Patients with advanced bladder cancer tend to be older, have multiple medical conditions and often have poor access to health care. An ENST may be an effective method to improve participation in treatment decision-making and care planning among patients with locally advanced, metastatic and unresectable bladder cancer and their caregivers.
Key Dates
- Start date
- Jan 12, 2024
- Status verified
- Jan 2026
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Supportive Care (ENST)Patients and caregivers receive access to the bladder cancer ENST and patients undergo psychological distress and nutrition screenings and may attend social work, psychology, and/or nutrition consultations as appropriate throughout the study. Patients, caregivers, and providers also attend virtual support group meetings periodically on study.
Primary Outcome Measure
Organizational readiness for implementing change (ORIC) [ Time Frame: At baseline and at 6 months post-implementation ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | Saby George, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Buffalo, NY
Related Studies
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsPHASE2 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant HistologyPHASE2 · Recruiting · Emory University · Atlanta, Georgia
- Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric AssessmentsRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid TumorsPHASE2 · Recruiting · Northwestern University · Chicago, Illinois